UK animal rights group slammed for "misleading claims"

30 July 2006

The UK's Advertising Standards Authority has criticized an animal rights group for printing misleading claims on animal suffering in scientific research. The National Anti-Vivisection Society had produced a campaigning leaflet, saying: "laboratory animals suffer terribly at every stage of their lives." The Research Defence Society, a pro-animal research group, complained about the leaflets to the ASA.

The RDS recognizes that some animals suffer during scientific research and that many animals experienced stress or discomfort at various times. However, the NAVS claim that all animals suffered at every stage is disputed, especially as many are used for breeding, for observation or as part of a control group. In other cases, the RDS argues that any suffering may be minimal or short-lived.

The ASA's ruling stated that the NAVS' claims were unsubstantiated and criticized the group for failing to respond to requests for information about the basis for the leaflet's claims. In a statement, the NAVS claimed not to have receive any communications from the ASA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight